Study Information

Alliance Study ID: NCCTG-937202

NCT Study ID (ClinicalTrials.gov): NCT00002806

Disease or Cancer Type: Brain / Central Nervous System Cancer

Alliance Study Chair: Jan C. Buckner, MD

Status: COMPLETED


Study Description

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining radiation therapy with chemotherapy may kill more tumor cells.

PURPOSE: Phase II trial to study the effectiveness of procarbazine, lomustine, and vincristine followed by radiation therapy in treating adults who have supratentorial glioma.

Related Publications

For publications related to this and other clinical trials, visit the Alliance Publications Application.

Data Sources & Contacts

Related Alliance Trials